High Dissolving Food for Facial Reconstruction
Trial Summary
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment High Dissolving Transitional Food for facial reconstruction?
The research suggests that transitional foods, like the Savorease cracker, dissolve well in the mouth, which can be beneficial for people who have difficulty chewing or swallowing. This property might help improve nutrition and mealtime satisfaction for those on modified texture diets, potentially aiding recovery in facial reconstruction.12345
Is High Dissolving Food for Facial Reconstruction safe for humans?
The safety of texture-modified diets (TMDs), which are similar to High Dissolving Food, has been evaluated for people with swallowing difficulties. These diets are designed to be safe for swallowing, but they may have risks related to nutrition intake, as they can lead to lower energy and protein consumption compared to regular diets.678910
How does the High Dissolving Food treatment for facial reconstruction differ from other treatments?
The High Dissolving Food treatment is unique because it uses transitional foods that dissolve easily in the mouth, which can be beneficial for individuals with difficulties in chewing or swallowing. This approach focuses on optimizing eating pleasure and nutrition by using foods that dissolve quickly, unlike traditional solid foods that may require more effort to consume.12111213
What is the purpose of this trial?
This is a prospective comparative study, where patients who meet inclusion criteria undergoing a craniofacial procedure will either be provided with novel high dissolving transitional foods for use in the post-operative period (Intervention Group) or will not be provided the food and will proceed as per current standard of care (Standard of Care Group). Both groups will be followed pre-operatively at time of pre-operative visit, and will be followed in the post-operative period, with two visits at 1 and 3 weeks post-operatively, respectively.
Research Team
Roberto Flores, MD
Principal Investigator
NYU Langone Health
Eligibility Criteria
This trial is for patients undergoing craniofacial procedures. Participants will be those who meet specific criteria to ensure they are suitable for the study, but detailed inclusion and exclusion criteria have not been provided.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-operative
Participants are assessed at the pre-operative visit, including wound examination and weight measurement
Post-operative
Participants receive either novel high dissolving transitional foods or standard care, with follow-up visits to assess wound issues and weight
Follow-up
Participants are monitored for safety and effectiveness, including 30-day readmission rate
Treatment Details
Interventions
- High Dissolving Transitional Food
Find a Clinic Near You
Who Is Running the Clinical Trial?
NYU Langone Health
Lead Sponsor